Innovation grants
Deadline dates
Note that this program is not being offered. For information only.
Please review the eligibility and requirements section prior to creating an application.
Previously funded grants through this competition are available here.
Please note:
- this competition consists of a full application only, abstract registration is not required
- there must be no (0%) overlap with any pending or held grant applications (i.e. 100% unique aims are required - conceptual overlap is acceptable but must be described by the applicant)
Application guides can be found on the EGrAMS documentation for applicants page.
Program description @(Model.HeadingTag)>
Innovation Grants support the highest quality creative problem solving in cancer research. The goal of the Innovation program is to support the development and testing of transformative, paradigm-shifting concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate novel approaches to confront the challenges we face in defeating cancer.
Successfully funded Innovation projects are ideally based on “high risk” ideas that have a strong potential for “high reward”. They are feasible and doable by the applicant(s), but not necessarily based on a significant amount of preliminary data. With a significant emphasis on innovation, this program encourages bold attempts to test novel hypotheses and/or generate new knowledge and/or improvements related to cancer prevention, detection, diagnosis, treatment, and support. Applications are encouraged from across all areas and disciplines of cancer research, as well as from investigators in other disciplines whose ideas are relevant to the field of cancer research.
It is hoped that this program will accelerate the introduction of innovation into the entire cancer research system and contribute to the scientific idea pipeline. Proposals with high scientific merit that are deemed derivative or formulaic, pursue next logical steps, or seek to make incremental advancements are not considered innovative and should not be submitted to this competition. Applicants are also cautioned to avoid overly-ambitious aims or aims that are not clearly connected - significant findings from investigators funded by Innovation Grants may be developed further through a CCS "Innovation to Impact" Grant.
Applicants are encouraged to review past competition results for examples of funded projects.
Funds available
It is anticipated that approximately 30 grants will be awarded in this competition.
Special funding calls within the Innovation Grant competition envelope:
- Applications relevant to breast cancer research are encouraged
- Applications relevant to skin cancer are encouraged
- As a result of a generous donation, funding for one application with a focus on early detection, diagnosis, and/or treatment of malignant mixed Müllerian tumours (MMMT) is available
- Additional funds may be available from the Lotte and John Hecht Memorial Foundation to support innovative projects focused on the application of complementary and alternative approaches in cancer treatment and control
Grant budgets may be up to $100,000 per year and a maximum of $200,000 per grant. Grant expenditures may be extended over 3 years if justified in the application. Grants will be non-renewable.
Funding will be provided to support the direct costs of research, including supplies, salaries, and equipment associated with the proposed work. Equipment requests cannot exceed 25% of the requested budget. Indirect costs are not eligible.
Peer review panels
Multidisciplinary peer review committees will be assembled to review the full applications. Peer review committees will consist of scientific experts with broad expertise, along with patient/survivor/caregiver participants, as applicable.
Review panel information can be found below. Please review carefully before making your panel selection, however, CCS reserves the right to determine the panel with the greatest expertise to review the application. Panel composition will be finalized after the Full Application deadline, based on the best fit for each application.
Partner Description @(Model.HeadingTag)>
Founded in 1962 to support charitable causes in Vancouver, the Lotte & John Hecht Memorial Foundation has since broadened its mandate to include the investigation and support of complementary and alternative medicine, particularly in the treatment of cancer. As part of its support for health research, the Foundation has partnered with Canadian Cancer Society (CCS) since 2012 to support relevant research projects in the CCS Innovation, i2I and Impact Grant programs.
Last modified on: May 4, 2020